Rosuvastatin preserves renal structure following unilateral ureteric obstruction in the neonatal rat

American Journal of Nephrology

Volumn 35, Issue 2, 2012, Pages 103-113

  Mazzei, Luciana Jorgelina ^a   García, Isabel Mercedes ^a   Altamirano, Liliana ^b   Docherty, Neil G ^c   Manucha, Walter ^a,b  

^a Universidad Nacional de Cuyo Facultad de Ciencias Medicas   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Fibrosis; Neonatal obstruction; Nephropathy; UUO rosuvastatin

Indexed keywords

COLLAGEN; MESSENGER RNA; OSTEOGENIC PROTEIN 1; ROSUVASTATIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; GENE EXPRESSION; GLOMERULUS; KIDNEY INJURY; KIDNEY STRUCTURE; KIDNEY TUBULE; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URETER OBSTRUCTION;

ANIMALS; APOPTOSIS; BONE MORPHOGENETIC PROTEIN 7; CADHERINS; FEMALE; FIBROSIS; FLUOROBENZENES; GENE EXPRESSION; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; PYRIMIDINES; RATS; RATS, INBRED WKY; RNA, MESSENGER; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION; WT1 PROTEINS;

EID: 84855175616     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000334935     Document Type: Article

References (30)

1. Becker A, Baum M: Obstructive uropathy. Early Hum Dev 2006; 82: 15-22. (Pubitemid 43163035)
2. Ahmadzadeh A, Tahmasebi M, Gharibvand MM: Causes and outcome of prenatally diagnosed hydronephrosis. Saudi J Kidney Dis Transpl 2009; 20: 246-250.
3. Docherty NG, O'Sullivan OE, Healy DA, Fitzpatrick JM, Watson RW: Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am J Physiol Renal Physiol 2006; 290:F4-F13.
4. Power RE, Doyle BT, Higgins D, Brady HR, Fitzpatrick JM, Watson RW: Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent. J Urol 2004; 171: 457-461. (Pubitemid 37549211)
5. Cachat F, Lange-Sperandio B, Chang AY, Kiley SC, Thornhill BA, Forbes MS, Chevalier RL: Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 2003; 63: 564-575. (Pubitemid 36126802)
6. Manucha W: Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 2007; 31: 1-12. (Pubitemid 46797814)
7. Dendooven A, Ishola DA Jr, Nguyen TQ, Van Der Giezen DM, Kok RJ, Goldschmeding R, Joles JA: Oxidative stress in obstructive nephropathy. Int J Exp Pathol 2011; 92: 202-210.
8. Manucha W, Carrizo L, Ruete C, Molina H, Vallés P: Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP-70) expression in obstructive nephropathy. Cell Mol Biol (Noisy-le-grand) 2005; 8;51: 547-555. (Pubitemid 41696412)
9. Manucha W, Carrizo L, Ruete C, Vallés PG: Apoptosis induction is associated with decreased NHE1 expression in neonatal unilateral ureteric obstruction. BJU Int 2007; 100: 191-198. (Pubitemid 46878536)
10. Meldrum KK, Metcalfe P, Leslie JA, Misseri R, Hile KL, Meldrum DR: TNF-α neutralization decreases nuclear factor-κ B activation and apoptosis during renal obstruction. J Surg Res 2006; 131: 182-188.
11. Truong LD, Gaber L, Eknoyan G: Obstructive uropathy. Contrib Nephrol. Basel, Karger, 2011, vol 169, pp 311-326.
12. Kones R: Rosuvastatin, inflammation, Creactive protein, JUPITER, and primary prevention of cardiovascular disease: A perspective. Drug Des Devel Ther 2010; 4: 383-413.
13. Mizuguchi Y, Miyajima A, Kosaka T, Asano T, Asano T, Hayakawa M: Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. J Urol 2004; 172: 2456-2459. (Pubitemid 39507552)
14. Vieira JM Jr, Mantovani E, Rodrigues LT, Dellê H, Noronha IL, Fujihara CK, Zatz R: Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 2005; 20: 1582-1591. (Pubitemid 41418580)
15. Tian S, Ding G, Jia R, Chu G: Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colony-stimulating factor: Implication for the role of atorvastatin. Mediators Inflamm 2006; 12919.
16. Mazzei L, García IM, Cacciamani V, Benardón ME, Manucha W: WT-1 mRNA expression is modulated by nitric oxide availability and Hsp70 interaction after neonatal unilateral ureteral obstruction. Biocell 2010; 34: 121-132.
17. Manucha W, Kurbán F, Mazzei L, Benardón ME, Bocanegra V, Tosi MR, Vallés P: ENOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy. Eur J Pharmacol 2011; 650: 487-495.
18. Manucha W, Vallés PG: Cytoprotective role of nitric oxide associated with Hsp70 expression in neonatal obstructive nephropathy. Nitric Oxide 2008; 18: 204-215.
19. Morrissey J, Hruska K, Guo G, Wang S, Chen Q, Klahr S: Bone morphometric protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 2002; 13:S14-S21. (Pubitemid 34008173)
20. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J: Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol (Renal Physiol) 2000; 279:F130-F143. (Pubitemid 30619554)
21. Ferder L, Inserra F, Romano L, Ercole L, Pszenny V: Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors. J Am Soc Nephrol 1994; 5: 1147-1152. (Pubitemid 24977094)
22. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteousl D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, et al: The candidate Wilms' tumour gene is involved in genitourinary development. Nature 1990; 346: 194-197.
23. Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD: E-cadherin is a WT-1 target gene. J Biol Chem 2000; 275: 10943-10953.
24. Manson SR, Niederhoff RA, Hruska KA, Austin PF: The BMP-7-Smad1/5/8 pathway promotes kidney repair after obstruction induced renal injury. J Urol 2011; 185(suppl): 2523-2530.
25. Chevalier RL, Thornhill BA, Chang AY, Cachat F, Lackey A: Recovery from release of ureteral obstruction in the rat: Relationship to nephrogenesis. Kidney Int 2002; 61: 2033-2043. (Pubitemid 34539321)
26. Quaggin SE, Kreidberg JA: Development of the renal glomerulus: Good neighbors and good fences. Development 2008; 135: 609-620. (Pubitemid 351405014)
27. Ratliff B, Rodebaugh J, Sekulic M, Solhaug M: Glomerular eNOS gene expression during postnatal maturation and AT1 receptor inhibition. Pediatr Nephrol 2007; 22: 1135-1142.
28. Ratliff B, Rodebaugh J, Sekulic M, Dong KW, Solhaug M: Nitric oxide synthase and reninangiotensin gene expression and NOS function in the postnatal renal resistance vasculature. Pediatr Nephrol 2009; 24: 355-365.
29. Kalaitzidis RG, Elisaf MS: The role of statins in chronic kidney disease. Am J Nephrol 2011; 34: 195-202.
30. Campese VM, Park J: HMG-CoA reductase inhibitors and the kidney. Kidney Int 2007; 71: 1215-1222. (Pubitemid 46884244)